Ravolution / Evidence

    AMBITION EARNS ATTENTION.
    PRECISION EARNS TRUST.

    Every large claim on this site should resolve into evidence. This register shows what is protected, what is pending, what is stealth — and what is still hypothesis.

    01 / IP register

    WHAT IS PROTECTED.

    Filing numbers, priority dates and claim schedules per asset are shared with qualified investors, institutions and acquirers under NDA.

    IDInventionMissionOwnerStatusJurisdiction
    IP-001Rosetta Livingstone02 LanguageRavolution ABGrantedSE / EP
    IP-002iApply04 OpportunityRavolution ABGrantedSE / EP
    IP-003CommunicaringSchool01 LearnRavolution ABGrantedSE
    IP-004XportMatch04 OpportunityRavolution ABGrantedSE
    IP-005VoiceProtector03 TrustRavolution ABGrantedSE
    IP-006It's a Fitt05 Healthier choicesRavolution AB (co-owned)GrantedSE
    IP-007Eventor04 OpportunityRavolution ABApplication filedSE
    IP-008Givin04 OpportunityRavolution ABApplication filedSE
    IP-009AlarmSole03 Trust & safetyRavolution ABPatent pendingSE / PCT route
    IP-010PikpCash (26 claims)04 OpportunityRavolution ABPatent pendingSE
    IP-011Gyrocraft06 Human capabilityRavolution ABApplication filed · restrictedDisclosed under NDA
    IP-012Frontier vertical06 Human capabilityRavolution ABStealthDisclosed post-qualification
    02 / Claim basis

    WHERE EVERY NUMBER COMES FROM.

    Large claims are not softened. They are backed up — or clearly marked as model, pilot or hypothesis.

    28 patent assets · 369 claims

    Portfolio count across granted, filed and pending assets in nine strategic verticals. Exact status, filing numbers and priority dates are supplied per asset in a qualified review.

    Language acquisition acceleration

    Internal method comparison against conventional classroom hours. Model and assumptions supplied on request; not an independently audited result.

    Consumer risk scoring (TOXINSIDE)

    Scores derive from published regulatory sources and cited ingredient databases. Methodology is public; no health claim is made for individual users.

    Return / conversion improvements

    Model-based projections from pilot data. Treated as hypothesis until independently measured in a customer deployment.